These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8913268)

  • 41. Solid phase-assisted synthesis and screening of a small library of N-(4-hydroxyphenyl)retinamide (4-HPR) analogs.
    Mershon SM; Anding AL; Chapman JS; Clagett-Dame M; Stonerock LA; Curley RW
    Bioorg Med Chem Lett; 2007 Feb; 17(3):836-40. PubMed ID: 17112722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
    Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antimitotic effect of the retinoid 4-oxo-fenretinide through inhibition of tubulin polymerization: a novel mechanism of retinoid growth-inhibitory activity.
    Appierto V; Tiberio P; Cavadini E; Casalini P; Cappelletti G; Formelli F
    Mol Cancer Ther; 2009 Dec; 8(12):3360-8. PubMed ID: 19996280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-(4-hydroxyphenyl)retinamide inhibits invasion, suppresses osteoclastogenesis, and potentiates apoptosis through down-regulation of I(kappa)B(alpha) kinase and nuclear factor-kappaB-regulated gene products.
    Shishodia S; Gutierrez AM; Lotan R; Aggarwal BB
    Cancer Res; 2005 Oct; 65(20):9555-65. PubMed ID: 16230421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
    Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
    Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
    Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
    J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and tamoxifen (TAM) for estrogen receptor (ER)-negative breast cancer.
    Aoyama Y
    Kurume Med J; 2002; 49(1-2):27-33. PubMed ID: 12235869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined effect of chemopreventive agent N-(4-hydroxyphenyl) retinamide (4-HPR) and gamma-radiation on bladder cancer cell lines.
    Zou C; Wang L; Liebert M; Grossman HB; Lotan R; Wei Q
    Int J Oncol; 1998 Nov; 13(5):1037-41. PubMed ID: 9772297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.
    Simeone AM; Broemeling LD; Rosenblum J; Tari AM
    Oncogene; 2003 Oct; 22(43):6739-47. PubMed ID: 14555987
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP; Slusher R; Ramalingam S; Gadgeel S; Mabry M
    J Natl Cancer Inst; 1995 Nov; 87(22):1674-80. PubMed ID: 7473815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
    Kabbout M; Hatoum A; Abou-Lteif G; Chakroun I; Homaidan FR; Darwiche N
    Mol Carcinog; 2004 May; 40(1):12-23. PubMed ID: 15108326
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-(4-hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T lymphoblastoid leukemia cells.
    Chan LN; Zhang S; Shao J; Waikel R; Thompson EA; Chan TS
    Leuk Lymphoma; 1997 Apr; 25(3-4):271-80. PubMed ID: 9168437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
    Anding AL; Chapman JS; Barnett DW; Curley RW; Clagett-Dame M
    Cancer Res; 2007 Jul; 67(13):6270-7. PubMed ID: 17616685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast tissue accumulation of retinamides in a randomized short-term study of fenretinide.
    Sabichi AL; Modiano MR; Lee JJ; Peng YM; Xu MJ; Villar H; Dalton WS; Lippman SM
    Clin Cancer Res; 2003 Jul; 9(7):2400-5. PubMed ID: 12855611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
    Teixeira C; Reed JC; Pratt MA
    Cancer Res; 1995 Sep; 55(17):3902-7. PubMed ID: 7641210
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
    Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
    Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: possible relation to high bcl-2/bax ratio?
    Lilling G; Hacohen H; Nordenberg J; Livnat T; Rotter V; Sidi Y
    Cancer Lett; 2000 Dec; 161(1):27-34. PubMed ID: 11078910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of aromatase activity and expression in MCF-7 cells by the chemopreventive retinoid N-(4-hydroxy-phenyl)-retinamide.
    Ciolino HP; Wang TT; Sathyamoorthy N
    Br J Cancer; 2000 Aug; 83(3):333-7. PubMed ID: 10917548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
    Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
    Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.